Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW – Get Rating) saw a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 1,300 shares, a decline of 13.3% from the July 31st total of 1,500 shares. Based on an average trading volume of 15,800 shares, the days-to-cover ratio is currently 0.1 days.
Intelligent Medicine Acquisition Price Performance
Shares of Intelligent Medicine Acquisition stock remained flat at $0.10 on Wednesday. The company had a trading volume of 10,900 shares, compared to its average volume of 18,363. Intelligent Medicine Acquisition has a 1 year low of $0.03 and a 1 year high of $0.60.
Get Intelligent Medicine Acquisition alerts:Intelligent Medicine Acquisition Company Profile
(Get Rating)
Intelligent Medicine Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.See Also
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMDW)
- Crowdstrike Stock Retraces, As Earnings Sober Expectations
- Will The Institutions Buy The Dip In Ambarella Stock?
- PVH Corporation Is On Track For Capital Returns
- Can Pinterest Rally On Support From Big Investor With Conviction?
- Chargepoint Rallies, Despite Weaker Earnings
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.